Beyond Air (XAIR) Stock Price

Beyond Air Price

NASDAQ·CLOSED
2.54
​
Market closed

Revenue at Beyond Air has contracted by 0.1% per year over the past 7 years to 7.68 M USD. For Beyond Air, the net margin of -433.0% is up versus -29,738.3% a few years ago. The consensus 12-month price target for Beyond Air is 8.67 USD, about 241.3% above where the stock trades today. Of 11 analysts, 9 rate the stock a buy — an overall Buy consensus.

Beyond Air stock price

Access this data via the Eulerpool API

Beyond Air business model & stock analysis

Beyond Air, Inc. is a clinical-stage medical device and biopharmaceutical company. The company is headquartered in Garden City, New York and currently employs 23 full-time employees. The company went IPO on 2019-05-07. The firm is focused on developing a nitric oxide (NO) generator and delivery system that generates NO from ambient air. The Beyond Air NOGDS is designed to deliver a dosage of NO to the lungs. The firm focuses on areas, such as persistent pulmonary hypertension of the newborn (PPHN), bronchiolitis (BRO) and nontuberculous mycobacteria (NTM). Its Beyond Air NOGDS also delivers a high concentration of NO to the lungs. The Company’s products include Beyond Air- PH, Beyond Air- BRO and Beyond Air- NTM.

Frequently asked questions about Beyond Air

Analysts currently set an average price target of 9.18 USD for the Beyond Air stock (median: 8.67 USD), implying +261.4 % versus the latest price. The consensus is based on 11 analyst ratings.

7 analysts currently rate the Beyond Air stock: 6 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Beyond Air share trades at 2.27 EUR (2.54 USD).

The Beyond Air share (XAIR) is listed on 4 stock exchanges, including: NASDAQ (XAIR), Frankfurt (48L.F), München (48L.MU), Düsseldorf (48L.DU).

The revenue of Beyond Air is 7.68 M USD. This figure is based on current financial data and reflects the company's business performance.

The profit of Beyond Air is -33.25 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Beyond Air is currently -0.06. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Beyond Air stock.

The price-to-sales ratio (P/S) of Beyond Air is currently 0.24. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Beyond Air stock.

The Eulerpool Quality Score for Beyond Air is 3/10.

The ISIN of Beyond Air is US08862L2025. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Beyond Air is A2PNGL. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Beyond Air is XAIR. The ticker symbol is used to trade Beyond Air shares on the stock exchange.

Fair ValueTerminal
2.31 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
333,869.57 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
May 7, 2019
ISIN
US08862L2025
Cusip
08862L103
Sedol
BKLTT19
Market capitalization
8.60 M USDMicro Cap
52-Week Range
PEG
0.00
P/E ratio
P/Ee 2027
-0.01
P/Ee 2028
-0.02
P/Ee 2029
-0.15
P/Ee 2030
-1.00
P/Ee 2031
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
1.40
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-112.67 %
Last updated Oct 8, 2026, 10:36 PM

Beyond Air Ticker

DÜSSELDORF · 48L.DUFRANKFURT · 48L.FMUNICH · 48L.MUNASDAQ · XAIR

All fundamentals and in-depth analysis of Beyond Air

Our stock analysis for Beyond Air stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Beyond Air. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.